JMP Securities Downgrades Haemonetics (HAE) to Market Perform

JMP Securities downgraded Haemonetics (NYSE: HAE) from Market Outperform to Market Perform and removed its price target (priro $45.00).

For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.

Shares of Haemonetics closed at $37.19 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
• BofA Securities Downgrades PG&E Corporation (PCG) to Neutral, 'A comprehensive reform opportunity falls short'
• Citi Downgrades REA Group Ltd. (REA:AU) (RPGRY) to Neutral